The Safety and Efficacy of a Transbronchial Lung Cryobiopsy Using a 1.7-mm Cryoprobe in Older Adult Patients with Suspected Interstitial Lung Disease: A Single-center, Retrospective, Observational Study
Abstract
Objective The safety and efficacy of a transbronchial lung cryobiopsy (TBLC) in older adult patients have not yet been fully established. We assessed the safety and clinical utility of TBLC in older adult Japanese patients with suspected interstitial lung disease (ILD). Methods We retrospectively reviewed the medical data of patients who underwent TBLC with a 1.7-mm cryoprobe for suspected ILD at the National Hospital Organization Okayama Medical Center between June 2022 and August 2024. Data on complications, diagnostic yield, and treatment after TBLC were collected and analyzed. Patients The patients were divided into two groups: an older adult group (OA group; age ≥70 years; n=31) and a non-older adult group (NOA group; age <70 years; n=19). Results The median age of the patients in the OA group was 72 years. Pneumothorax occurred only in the NOA group (p=0.017), whereas the frequencies of other complications did not differ significantly. No severe complications were noted. The severity of bleeding did not differ significantly between the groups, regardless of the hemostatic method used (p=0.690). The overall diagnostic yield was 82% (OA group: 84%; NOA group: 79%; p=0.715). Idiopathic pulmonary fibrosis was significantly more common in the OA group than in the NOA group (p=0.035), whereas hypersensitivity pneumonitis was significantly more common in the NOA group than in the OA group (p=0.013). Conclusion TBLC may help diagnose ILD in older adult patients, particularly in those with a preserved respiratory function and no apparent contraindications.
Related
- Prospective Case Series to Determine the Feasibility, Diagnostic Yield and Safety of Performing EBUS Guided Trans‐Bronchial Mediastinal Cryobiopsy (EBUS‐TBMC) of Lymph Nodes Using 1.1 mm Cryoprobe Through a Working Channel of Linear EBUS Bronchoscope Versus Conventional En‐Bloc Cryobiopsy
- Dual-scope method for hemostasis during transbronchial lung cryobiopsy : A two-patient case report
- Eosinophilic Bronchiolitis Diagnosed by a Transbronchial Lung Cryobiopsy and Successfully Treated with Biologic Agents: A Report of Two Cases and Literature Review
- Pulmonary Hamartoma Diagnosed by Transbronchial Mediastinal Cryobiopsy Additional to Needle Aspiration: A Case Report
- A Case of Recurrent COVID-19 Pneumonia Following Rituximab Therapy: Treatment Informed by a Serial Transbronchial Lung Cryobiopsy, BALF SARS-CoV-2 PCR, and the Clinical Course
BibTeX
@article{fujiwara2026safety,
title = {{The Safety and Efficacy of a Transbronchial Lung Cryobiopsy Using a 1.7-mm Cryoprobe in Older Adult Patients with Suspected Interstitial Lung Disease: A Single-center, Retrospective, Observational Study}},
author = {Miho Fujiwara and Yuki Takigawa and Ken Sato and Tomoyoshi Inoue and Suzuka Matsuoka and Hiromi Watanabe and Kenichiro Kudo and Akiko Sato and Keiichi Fujiwara and Takuo Shibayama},
journal = {Internal Medicine},
year = {2026},
month = oct,
doi = {10.2169/internalmedicine.6521-25},
url = {https://www.jstage.jst.go.jp/article/internalmedicine/65/20/65_6521-25/_article},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - The Safety and Efficacy of a Transbronchial Lung Cryobiopsy Using a 1.7-mm Cryoprobe in Older Adult Patients with Suspected Interstitial Lung Disease: A Single-center, Retrospective, Observational Study
AU - Miho Fujiwara
AU - Yuki Takigawa
AU - Ken Sato
AU - Tomoyoshi Inoue
AU - Suzuka Matsuoka
AU - Hiromi Watanabe
AU - Kenichiro Kudo
AU - Akiko Sato
AU - Keiichi Fujiwara
AU - Takuo Shibayama
PY - 2026
DA - 2026/10/15
JO - Internal Medicine
DO - 10.2169/internalmedicine.6521-25
UR - https://www.jstage.jst.go.jp/article/internalmedicine/65/20/65_6521-25/_article
AB - Objective The safety and efficacy of a transbronchial lung cryobiopsy (TBLC) in older adult patients have not yet been fully established. We assessed the safety and clinical utility of TBLC in older adult Japanese patients with suspected interstitial lung disease (ILD). Methods We retrospectively reviewed the medical data of patients who underwent TBLC with a 1.7-mm cryoprobe for suspected ILD at the National Hospital Organization Okayama Medical Center between June 2022 and August 2024. Data on complications, diagnostic yield, and treatment after TBLC were collected and analyzed. Patients The patients were divided into two groups: an older adult group (OA group; age ≥70 years; n=31) and a non-older adult group (NOA group; age <70 years; n=19). Results The median age of the patients in the OA group was 72 years. Pneumothorax occurred only in the NOA group (p=0.017), whereas the frequencies of other complications did not differ significantly. No severe complications were noted. The severity of bleeding did not differ significantly between the groups, regardless of the hemostatic method used (p=0.690). The overall diagnostic yield was 82% (OA group: 84%; NOA group: 79%; p=0.715). Idiopathic pulmonary fibrosis was significantly more common in the OA group than in the NOA group (p=0.035), whereas hypersensitivity pneumonitis was significantly more common in the NOA group than in the OA group (p=0.013). Conclusion TBLC may help diagnose ILD in older adult patients, particularly in those with a preserved respiratory function and no apparent contraindications.
SN - 1349-7235
SN - 0918-2918
ER -